Fundz

Aspen Neuroscience Appoints Revati Shreeniwas as Chief Medical Officer and Lisa Johnson-Pratt as Chief Commercial Officer

PRIVATEJan 07, 2026

Position

Chief Medical Officer

Company

Aspen Neuroscience

Revati Shreeniwas
rshreeniwas@aspenneuro.com
San DiegoBiotechnologyHealth CareScience And Engineering

Description

Aspen Neuroscience has announced the appointments of Revati Shreeniwas, MD as Chief Medical Officer and Lisa Johnson-Pratt, MD as Chief Commercial Officer. These executive positions are aimed at strengthening the company's late-stage development and commercial readiness for its regenerative therapies for Parkinson's disease.

Quick answer

Aspen Neuroscience Appoints Revati Shreeniwas as Chief Medical Officer and Lisa Johnson-Pratt as Chief Commercial Officer (January 7, 2026). Aspen Neuroscience is based in San Diego, California, United States.

Who is the new Chief Medical Officer at Aspen Neuroscience?
Aspen Neuroscience named Revati Shreeniwas Chief Medical Officer, announced January 7, 2026.
What did Aspen Neuroscience announce on January 7, 2026?
Aspen Neuroscience has announced the appointments of Revati Shreeniwas, MD as Chief Medical Officer and Lisa Johnson-Pratt, MD as Chief Commercial Officer. These executive positions are aimed at strengthening the company's late-stage development and commercial readiness for its regenerative therapies for Parkinson's disease.
What does Aspen Neuroscience do?
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and...
Where is Aspen Neuroscience based?
Aspen Neuroscience is based in San Diego, California, United States.
Which similar companies made leadership changes around the same time?
Psilera (January 8, 2026), Septerna (January 8, 2026), Charles River Laboratories (January 12, 2026) and Cardiff Oncology (January 27, 2026) also announced leadership changes within 45 days of Aspen Neuroscience.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Aspen Neuroscience, and when

A new leader at Aspen Neuroscience brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Aspen Neuroscience raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aspen Neuroscience, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aspen Neuroscience. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aspen Neuroscience

Location

10835 Road to the Cure, Ste. 100

San Diego, California, United States

About

Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aspen Neuroscience changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ana
Likely contact at this company
••••••••@••••••••

See Ana's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aspen Neuroscience's next move

Learn about Strategic plan

Aspen Neuroscience changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.